Stock listing
Newcelx Ltd.
Selected listing: NCEL · NASDAQ · USD · US
Newcelx Ltd. (NASDAQ:NCEL), Health Technology. Latest release Sep 28, 2026: NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing…
- Ticker
- NASDAQ:NCEL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Newcelx Ltd.
Newcelx Ltd. (NCEL) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Newcelx Ltd.
NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes
September 28, 2026
NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing
July 31, 2026
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
July 8, 2026
NewcelX Publishes Peer-Reviewed Study Demonstrating Broad Therapeutic Potential of its Stem Cell Technology Platform
June 15, 2026
NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes
May 26, 2026